Related Posts
More Posts
Investor’s Business Daily: worthwhile?
NWA❗️
Got the call for this piece yesterday.

Any hot valuation topics people want to discuss?
Additional Posts in Consulting
New to Fishbowl?
Download the Fishbowl app to
unlock all discussions on Fishbowl.
unlock all discussions on Fishbowl.




Rising Star
Literally does not matter
Pro
Agreed lol
Pro
I think OW is more established, but I believe Kearney compensation is slightly higher at both levels. Kearney is also growing in this space. Pick who you vibe with more.
Chief
There’s a million other firms you should check out if you want to do pure life sciences
Pro
If you want to expand the Kearney is a great place to break out
Rising Star
Assuming this is Americas? My vote would be Kearney, but I think it also depends on what type of work you're aiming to do. For example, in the US, Kearney doesn't do much of "core" life sciences work at pharma clients (stuff like market access, R&D, etc.). My understanding is that with the acquisition of Huron, OW would do more in this space, for instance.
Just something to think about as both firms will have their strengths and gaps in the health space. Cheers!
Thanks! Hoping so as well :)
OW is expanding heavily into LS. Good place to be right now. Can’t comment on ATK.